Horizons Chronic Graft-Versus-Host-Disease Study (NCT06160986)

🧪 Interventions in This Study

• Horizons Group Intervention (BEHAVIORAL)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• University of Miami — Miami, Florida

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Graft Vs Host Disease

• Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD — New York, New York
• A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease — Toronto, Ontario
• Pediatric cGVHD Symptom Scale — Phoenix, Arizona
• Chronic GVHD Response Measures Validation — Seattle, Washington
• A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant — San Francisco, California

Explore by condition: All Graft Vs Host Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.